| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technical Ops Officer | SVP Cml Mfg & Supply Chain
1 company
Harpreet S. Dhaliwal is Chief Technical Ops Officer at PCVX. Harpreet S. Dhaliwal's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $4.1M at current prices.
The PCVX filings lean toward selling, a net 26,743 shares.
Harpreet S. Dhaliwal has 13 Form 4 filings on record from November 2021 to September 2026, all as Chief Technical Ops Officer at Vaxcyte (PCVX), 2021–2026.
The 22 reported transactions were 11 tax withholdings, 4 option or other derivative awards, 2 option exercises and 2 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.4M.
The largest open-market sale was 17,000 shares of PCVX at an average $55.00 on August 5, 2026, about $935K.
1 of the 2 sales since April 2023 was made under a Rule 10b5-1 trading plan; the other was not.